LipocineLPCN
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 22 institutions reported holding Lipocine Inc. (LPCN) in their 13F filings, up 4 from Q2 2025. 4 opened new positions and 0 sold out. The largest holders were Vanguard Group Inc. ($635K), BlackRock, Inc. ($254K) and Geode Capital Management, LLC ($175K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lipocine Inc.
- CUSIP
- 53630X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $41K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 18,140 shares bought and 17,288 shares sold, net +852 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Vanguard Group Inc. | 0.00% | Reduce -1.3% | 221,867 | $635K |
| BlackRock, Inc. | 0.00% | No change | 89,272 | $254K |
| Geode Capital Management, LLC | 0.00% | No change | 61,076 | $175K |
| Susquehanna International Group, LLP | 0.00% | Add +1.6% | 46,761 | $134K |
| Renaissance Technologies | 0.00% | Add +3.7% | 36,097 | $103K |
| State Street Corp. | 0.00% | No change | 18,626 | $53K |
| Citadel Advisors | 0.00% | New | 14,247 | $41K |
| Northern Trust Corp. | 0.00% | No change | 13,160 | $38K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -49.1% | 12,140 | $35K |
| Barclays PLC | 0.00% | No change | 9,412 | $27K |
| Osaic Holdings, Inc. | 0.00% | Reduce -0.8% | 2,268 | $6K |
| UBS Group AG | 0.00% | Add +271.8% | 1,766 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +73.8% | 1,170 | $3K |
| Morgan Stanley | 0.00% | No change | 575 | $2K |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 471 | $1K |
| Group One Trading LLC | 0.00% | No change | 162 | $463 |
| SBI Securities Co., Ltd. | 0.00% | No change | 67 | $191 |
| FMR LLC | 0.00% | New | 59 | $169 |
| Tidemark, LLC | 0.00% | No change | 59 | $168 |
| Bank of America Corp. | 0.00% | Reduce -98.1% | 49 | $139 |
| Citigroup Inc. | 0.00% | New | 3 | $9 |
| Royal Bank of Canada | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is LPCN's weight in each manager's 13F, not the share of Lipocine Inc. the manager owns.